Peripheral neuropathy associated with prolonged use of linezolid

Lancet Infectious Diseases

Volumn 4, Issue 8, 2004, Pages 528-531

  Bressler, Adam M ^a,b   Zimmer, Shanta M ^a   Gilmore, Jane L ^a   Somani, Jyoti ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GA ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; LINEZOLID; OXYCODONE; PENICILLIN G; RIFAMPICIN; SALBUTAMOL; TETRACYCLINE; THEOPHYLLINE; VANCOMYCIN;

ADULT; ANAMNESIS; ATAXIA; AXONAL INJURY; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DIARRHEA; DRUG HYPERSENSITIVITY; DRUG SENSITIVITY; FEMALE; GASTROENTERITIS; HUMAN; LONG TERM CARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NERVE CONDUCTION; OPTIC NERVE DISEASE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; SENSORIMOTOR FUNCTION; TREATMENT INDICATION; VOMITING;

ACETAMIDES; ANTI-INFECTIVE AGENTS; FEMALE; GROWTH; HUMANS; MIDDLE AGED; OXAZOLIDINONES; PERIPHERAL NERVOUS SYSTEM DISEASES; STAPHYLOCOCCAL INFECTIONS;

EID: 4043151561     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(04)01109-0     Document Type: Review

References (15)

1. Birmingham MC, Rayner CR, Meagher AK, Flavin SM, Batts DH, Schentag JJ. Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate use program. Clin Infect Dis. 36:2003;159-168
2. Corallo CE, Paull AE. Linezolid-induced neuropathy. Med J Aust. 177:2002;332
3. Lee E, Burger S, Shah J, et al. Linezolid-associated toxic optic neuropathy: a report of two cases. Clin Infect Dis. 37:2003;1389-1391
4. Moylett EH, Pacheco SE, Brown-Elliott BA, et al. Clinical experience with linezolid for the treatment of Nocardia infection. Clin Infect Dis. 36:2003;313-318
5. Apodaca AA, Rakita RM. Linezolid-induced lactic acidosis. N Engl J Med. 348:2003;86-87
6. Brown-Elliott BA, Wallace RJ, Griffith DE, et al. Safety and tolerance of long term therapy of linezolid for mycobacterial and nocardial disease with a focus on once daily therapy. Proceedings of the 40th Annual Infectious Disease Society of America; 2002 Oct 24-27; Chicago, IL, USA. Infectious Diseases Society of America, 2002: 151.
7. Gareca MG, Brown-Elliott BA, Wallace RJ. Successful treatment of a clarithromycin-resistant Mycobacterium chelonae infection with linezolid Proceedings of the 40th Annual Infectious Disease Society of America; 2002 Oct 24-27; Chicago, IL, USA. Infectious Diseases Society of America, 2002: 151.
8. Bergstermann KH, Neher A, Feldman K. Tolerability of linezolide in the long-term treatment of multiresistant pulmonary tuberculosis. Pneumologie. 55:(suppl 1):2001;S67
9. Lewis K, Ebden P, Wooster SL, Rees J, Harrison GAJ. Multi-system infection with Nocardia farcinica therapy with linezolid and minocycline. J Infect. 46:2003;199-202
10. Legout L, Senneville E, Gomel JJ, Yazdanpanah Y, Mouton Y. Linezolid-induced neuropathy. Clin Infect Dis. 38:2004;767-768
11. Zyvox (linezolid) product information. Kalamazoo, Michigan: Pharmacia Corporation, December 2002.
12. Sourdille MJ. Optic neuritis caused by monoamine oxidase inhibitors. Bull Soc Ophtalmol France. 64:1964;981-988
13. Hamada H, Saito T, Torii J. A case of opticoneuropathy due to treatment with monoamine oxidase inhibitor (safrazine). Rinsho Shinkeigaku. 19:1979;379-387
14. Leibold JE. Drugs having a toxic effect on the optic nerve. Int Ophthalmol Clin. 11:1971;137-157
15. Cunha BA. Antibiotic side effects. Med Clin North Am. 85:2001;149-185